These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16304728)

  • 41. Relationship of anticardiolipin antibodies and antiphospholipid syndrome to HLA-DR7 in Mexican patients with systemic lupus erythematosus (SLE).
    Granados J; Vargas-Alarcón G; Drenkard C; Andrade F; Melín-Aldana H; Alcocer-Varela J; Alarcón-Segovia D
    Lupus; 1997; 6(1):57-62. PubMed ID: 9116720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Anticardiolipin antibodies in systemic lupus erythematosus: clinical correlates, HLA associations, and impact on survival.
    Gulko PS; Reveille JD; Koopman WJ; Burgard SL; Bartolucci AA; Alarcón GS
    J Rheumatol; 1993 Oct; 20(10):1684-93. PubMed ID: 8295179
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Neurological disorders in systemic lupus erythematosus patients].
    Hawro T; Bogucki A; Sysa-Jedrzejowska A; Bogaczewicz J; Woźniacka A
    Pol Merkur Lekarski; 2009 Jan; 26(151):43-8. PubMed ID: 19391506
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-DPB1 alleles association of anticardiolipin and anti-beta2GPI antibodies in a large series of European patients with systemic lupus erythematosus.
    Sebastiani GD; Galeazzi M; Tincani A; Scorza R; Mathieu A; Passiu G; Morozzi G; Piette JC; Cervera R; Houssiau F; Smolen J; Fernandez Nebro A; De Ramon E; Goral AJ; Papasteriades C; Ferrara GB; Carcassi C; Bellisai F; Marcolongo R;
    Lupus; 2003; 12(7):560-3. PubMed ID: 12892399
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Elevated anticardiolipin antibodies in autoimmune haemolytic anaemia irrespective of underlying systemic lupus erythematosus.
    Lang B; Straub RH; Weber S; Röther E; Fleck M; Peter HH
    Lupus; 1997; 6(8):652-5. PubMed ID: 9364424
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus.
    Coín MA; Vilar-López R; Peralta-Ramírez I; Hidalgo-Ruzzante N; Callejas-Rubio JL; Ortego-Centeno N; Pérez-García M
    Lupus; 2015 Jul; 24(8):875-9. PubMed ID: 25697771
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Platelet activation induced by combined effects of anticardiolipin and lupus anticoagulant IgG antibodies in patients with systemic lupus erythematosus--possible association with thrombotic and thrombocytopenic complications.
    Nojima J; Suehisa E; Kuratsune H; Machii T; Koike T; Kitani T; Kanakura Y; Amino N
    Thromb Haemost; 1999 Mar; 81(3):436-41. PubMed ID: 10102474
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus.
    Steens SC; Bosma GP; Steup-Beekman GM; le Cessie S; Huizinga TW; van Buchem MA
    Arthritis Res Ther; 2006; 8(2):R38. PubMed ID: 16469116
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Longterm ultraviolet-A1 irradiation therapy in systemic lupus erythematosus.
    Molina JF; McGrath H
    J Rheumatol; 1997 Jun; 24(6):1072-4. PubMed ID: 9195511
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trends of anticardiolipin antibodies after low-dose methylprednisolone and cyclophosphamide treatment of systemic lupus erythematosus.
    Lavalle-Graef A; Villegas-Acosta L; Lavalle C
    Arch Med Res; 2004; 35(5):421-7. PubMed ID: 15610913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lipoprotein(a) levels in systemic lupus erythematosus.
    Borba EF; Santos RD; Bonfa E; Vinagre CG; Pileggi FJ; Cossermelli W; Maranhão RC
    J Rheumatol; 1994 Feb; 21(2):220-3. PubMed ID: 8182628
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quantification of antiribosomal P0 protein antibodies by ELISA with recombinant P0 fusion protein and their association with central nervous system disease in systemic lupus erythematosus.
    Yoshio T; Masuyama J; Ikeda M; Tamai K; Hachiya T; Emori T; Mimori A; Takeda A; Minota S; Kano S
    J Rheumatol; 1995 Sep; 22(9):1681-7. PubMed ID: 8523345
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical presentations and vascular histopathology in autopsied patients with systemic lupus erythematosus and anticardiolipin antibodies.
    Sipek-Dolnicar A; Hojnik M; Bozic B; Vizjak A; Rozman B; Ferluga D
    Clin Exp Rheumatol; 2002; 20(3):335-42. PubMed ID: 12102469
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anticardiolipin, anti-beta(2)-glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis.
    Swadzba J; De Clerck LS; Stevens WJ; Bridts CH; van Cotthem KA; Musial J; Jankowski M; Szczeklik A
    J Rheumatol; 1997 Sep; 24(9):1710-5. PubMed ID: 9292792
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients.
    Jouhikainen T; Julkunen H; Vaarala O; Leirisalo-Repo M; Stephansson E; Vahtera E; Palosuo T; Myllylä G
    Blood Coagul Fibrinolysis; 1992 Aug; 3(4):407-14. PubMed ID: 1420816
    [TBL] [Abstract][Full Text] [Related]  

  • 56. BF*F allotype of the alternative pathway of complement: A marker of protection against the development of antiphospholipid antibodies in patients with systemic lupus erythematosus.
    Picceli VF; Skare TL; Nisihara RM; Nass FR; Messias-Reason IT; Utiyama SR
    Lupus; 2016 Apr; 25(4):412-7. PubMed ID: 26537423
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort.
    Mikdashi J; Handwerger B
    Rheumatology (Oxford); 2004 Dec; 43(12):1555-60. PubMed ID: 15342927
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anticardiolipin antibodies in childhood rheumatic disorders.
    Gedalia A; Molina JF; García CO; Doggett S; Espinoza LR; Gharavi AE
    Lupus; 1998; 7(8):551-3. PubMed ID: 9863898
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ultraviolet-A1 irradiation decreases clinical disease activity and autoantibodies in patients with systemic lupus erythematosus.
    McGrath H
    Clin Exp Rheumatol; 1994; 12(2):129-35. PubMed ID: 8039279
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Livedo reticularis: a rare manifestation of Graves hyperthyroidism associated with anticardiolipin antibodies.
    Liel Y
    South Med J; 2004 Jun; 97(6):601-3. PubMed ID: 15255431
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.